Predictive biomarkers of response to bacillus Calmette-Guerin immunotherapy and bacillus Calmette-Guerin failure for non-muscle invasive bladder cancer

被引：5

作者：

Wang, Ziting ^{[1
]}

So, Wei Zheng ^{[1
]}

Loh, Kep Yong ^{[2
]}

Lim, Yew Koon ^{[1
]}

Mahendran, Ratha ^{[1
]}

Wu, Qing Hui ^{[1
]}

Chiong, Edmund ^{[1
]}

机构：

[1] Natl Univ Singapore Hosp, Dept Urol, 1E Kent Ridge Rd,Level 8, Singapore 119228, Singapore

[2] Singapore Gen Hosp, Dept Internal Med, Singapore, Singapore

来源：

INTERNATIONAL JOURNAL OF UROLOGY | 2022年 / 29卷 / 08期

关键词：

bladder cancer; immunotherapy; recurrence; TO-LYMPHOCYTE RATIO; CARCINOMA IN-SITU; EORTC RISK TABLES; UROTHELIAL CARCINOMA; EAU GUIDELINES; PROGNOSTIC-FACTORS; BCG IMMUNOTHERAPY; MONOCYTE RATIO; PRB EXPRESSION; T1;

D O I：

10.1111/iju.14921

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Within the heterogeneous population of patients with bacillus Calmette-Guerin failure, there are clear differences in prognosis and therapy with regard to the timeline when bacillus Calmette-Guerin failure occurred. There are a variety of classifications which include bacillus Calmette-Guerin refractory disease, relapsing, unresponsive, and intolerant. Further profiling of these patients may help to shed light on other forms of therapy that are less radical. We hereby summarize the different biomarkers that predicts for response to bacillus Calmette-Guerin immunotherapy and bacillus Calmette-Guerin failure for non-muscle invasive bladder cancer.

引用

页码：807 / 815

页数：9

共 64 条

[1] Lymphocyte-to-Monocyte Ratio Is the Independent Prognostic Marker of Progression in Patients Undergoing BCG-Immunotherapy for Bladder Cancer [J].

Adamkiewicz, Mateusz ;

Bryniarski, Piotr ;

Kowalik, Maksymilian ;

Burzynski, Bartlomiej ;

Rajwa, Pawel ;

Paradysz, Andrzej .

FRONTIERS IN ONCOLOGY, 2021, 11

[2] Evaluation of the Methylation Status of Tumour Suppressor Genes for Predicting Bacillus Calmette-Guerin Response in Patients With T1G3 High-Risk Bladder Tumours [J].

Agundez, Miriam ;

Grau, Laura ;

Palou, Joan ;

Algaba, Ferran ;

Villavicencio, Humberto ;

Sanchez-Carbayo, Marta .

EUROPEAN UROLOGY, 2011, 60 (01) :131-140

[3] Association of tumour necrosis factor-α gene (T-1031C, C-863A, and C-857T) polymorphisms with bladder cancer susceptibility and outcome after bacille Calmette-Guerin immunotherapy [J].

Ahirwar, Dinesh K. ;

Mandhani, Anil ;

Dharaskar, Anand ;

Kesarwani, Pravin ;

Mittal, Rama D. .

BJU INTERNATIONAL, 2009, 104 (06) :867-873

[4] Polyamine-modulated Factor-1 Methylation Predicts Bacillus Calmette-Guerin Response in Patients with High-grade Non-muscle-invasive Bladder Carcinoma [J].

Alvarez-Mugica, Miguel ;

Fernandez-Gomez, Jesus M. ;

Cebrian, Virginia ;

Fresno, Florentino ;

Escaf, Safwan ;

Sanchez-Carbayo, Marta .

EUROPEAN UROLOGY, 2013, 63 (02) :364-370

[5] EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder [J].

Babjuk, Marko ;

Oosterlinck, Willem ;

Sylvester, Richard ;

Kaasinen, Eero ;

Boehle, Andreas ;

Palou-Redorta, Juan .

EUROPEAN UROLOGY, 2008, 54 (02) :303-314

[6] European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ) [J].

Babjuk, Marko ;

Burger, Maximilian ;

Capoun, Otakar ;

Cohen, Daniel ;

Comperat, Eva M. ;

Escrig, Jose L. Dominguez ;

Gontero, Paolo ;

Liedberg, Fredrik ;

Masson-Lecomte, Alexandra ;

Mostafid, A. Hugh ;

Palou, Joan ;

van Rhijn, Bas W. G. ;

Roupret, Morgan ;

Shariat, Shahrokh F. ;

Seisen, Thomas ;

Soukup, Viktor ;

Sylvester, Richard J. .

EUROPEAN UROLOGY, 2022, 81 (01) :75-94

[7] European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)-2019 Update [J].

Babjuk, Marko ;

Burger, Maximilian ;

Comperat, Eva M. ;

Gontero, Paolo ;

Mostafid, A. Hugh ;

Palou, Joan ;

van Rhijn, Bas W. G. ;

Roupret, Morgan ;

Shariat, Shahrokh F. ;

Sylvester, Richard ;

Zigeuner, Richard ;

Capoun, Otakar ;

Cohen, Daniel ;

Dominguez Escrig, Jose Luis ;

Hernandez, Virginia ;

Peyronnet, Benoit ;

Seisen, Thomas ;

Soukup, Viktor .

EUROPEAN UROLOGY, 2019, 76 (05) :639-657

[8] EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016 [J].

Babjuk, Marko ;

Boehle, Andreas ;

Burger, Maximilian ;

Capoun, Otakar ;

Cohen, Daniel ;

Comperat, Eva M. ;

Hernandez, Virginia ;

Kaasinen, Eero ;

Palou, Joan ;

Roupret, Morgan ;

van Rhijn, Bas W. G. ;

Shariat, Shahrokh F. ;

Soukup, Viktor ;

Sylvester, Richard J. ;

Zigeuner, Richard .

EUROPEAN UROLOGY, 2017, 71 (03) :447-461

[9] EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013 [J].

Babjuk, Marko ;

Burger, Maximilian ;

Zigeuner, Richard ;

Shariat, Shahrokh F. ;

van Rhijn, Bas W. G. ;

Comperat, Eva ;

Sylvester, Richard J. ;

Kaasinen, Eero ;

Boehle, Andreas ;

Palou Redorta, Joan ;

Roupret, Morgan .

EUROPEAN UROLOGY, 2013, 64 (04) :639-653

[10] EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 Update [J].

Babjuk, Marko ;

Oosterlinck, Willem ;

Sylvester, Richard ;

Kaasinen, Eero ;

Boehle, Andreas ;

Palou-Redorta, Juan ;

Roupret, Morgan .

EUROPEAN UROLOGY, 2011, 59 (06) :997-1008

← 1 2 3 4 5 6 7 →